Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_assertion type Assertion NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_head.
- NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_assertion description "[Using reverse transcriptase-polymerase chain reaction (RT-PCR) to assess the mRNA levels of p53, p73 (total and isoforms specific for exons 2 and 13), MDM2, CDKN1A and beta2-microglobulin as internal control, we analyzed 35 prostate carcinomas and 44 benign prostate hyperplasias (BPH) compared to 14 normal prostates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_provenance.
- NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_assertion evidence source_evidence_literature NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_provenance.
- NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_assertion SIO_000772 15492805 NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_provenance.
- NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_assertion wasDerivedFrom befree-20140225 NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_provenance.
- NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_assertion wasGeneratedBy ECO_0000203 NP745124.RAgcmFUjWkdqdWM0FCLFP8NZ_pL2XZ7Ux4WOM54e8uYtA130_provenance.